Triple-negative breast cancer is viewed clinically as an aggressive subgroup of breast
cancer. In fact, most triple-negative breast cancers are poor-prognosis tumors with a …

Triple-negative breast cancers (TNBCs), defined by lack of expression of estrogen receptor,
progesterone receptor and HER2, account for 12–17% of breast cancers and are clinically …

Salivary glands that produce and secrete saliva, which is essential for lubrication, digestion,
immunity, and oral homeostasis, consist of diverse cells. The long-term maintenance of …

To report the standard of care, interesting new findings and controversies about the
treatment of parotid tumors. Relevant and actual studies were searched in PubMed and …

Salivary duct carcinoma (SDC) is an aggressive subtype of primary salivary gland
carcinoma, often with an advanced stage at presentation and high rates of metastasis and …

Adenomyoepithelioma of the breast is a rare tumor characterized by epithelial−
myoepithelial differentiation, whose genetic underpinning is largely unknown. Here we show …

Breast cancer (BC) is the most common women cancer and second most common cause of
cancer death in women. A woman living in the United States has 12.3% lifetime risk of being …

Breast cancer (BC) comprises a diverse spectrum of diseases featuring distinct presentation,
morphological, biological, and clinical phenotypes. BC behaviour and response to therapy …

Epithelial-myoepithelial carcinoma (EMC) is a rare salivary gland tumor that is histologically
characterized by biphasic tubular structures composed of inner ductal and outer clear …

Purpose: We sought to identify genomic alterations (GA) in salivary gland adenocarcinomas,
not otherwise specified (NOS), salivary duct carcinomas (SDC), carcinoma ex pleomorphic …